Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Mast Cell Activation Syndrome
Total 0 results
Nothing found
Sponsors and Collaborators
Aga Khan Foundation, Pakistan
YASEMİN AYDIN KARTAL
Axon Neuroscience SE
Sichuan Haisco Pharmaceutical Group Co., Ltd
Outpatient Endovascular and Interventional Society
Erzurum Regional Training & Research Hospital
Department of Anesthesiology, North Denmark Regional Hospital
Saint Pierre Institute - Palavas les Flots
Yancheng City NO.1 People's Hospital
Eastman Kodak Company
Invicta Medical Inc.
Gregorio Covino
Grünenthal Denmark ApS
CARITAS Rundum zu Hause betreut
Alessandra Palo
Doterra Healing Hands Foundation
CeRSM
EMET Pharmaceuticals, LLC
Phramongkutklao College of Medicine and Hospital
Irish Endocrine Society
View Full List
Medical Conditions
Bioequivalence, AUC, Cmax, Pharmacokinetics
Ferritin Threshold
Venous Puncture
Pelvic and Groin Areas Biopsy
Osteopathic Manipulative Treatment
Chondrosis
Acute Endophthalmitis Post-operative
Mineralocorticoid Excess
Neutrophilia Acute
HIV Pre-exposure Prophylaxis Use
Reading Disability
Major Depressive Disorder, Recurrent Episode, Severe
Central Motor Disorders
Abdominal Compartment Syndrome
Hemopathies
Human Risk Factors
Modality of Discharge Instructions
Hypogonadism, Hypogonadotropic
Pharmacokinetics of Plasma Phenolic Glucuronide of MPA (MPAG)
Skeletal Muscle Energy Metabolism
View Full List
Drug Interventions
Niraparib
Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen
Systemic intravenous lidocaine infusion
Lenalidomide
Leuprolide acetate 11.25 mg
Betamethasone
MYL-1501D product using manufacture process VI
Amantadine Sulfate
Enteral oxygen therapy
Pacritinib
Neridronate
Naltrexone 50 Mg + Inactive Marijuana (0% THC)
Ranitidine
LY2216684
Risperidone
Test varnish
Carbetocin
Pregabalin
Apatinib
Anti-PD1 antibody, nimotuzumab and capecitabine
View Full List
CROs by country
Contract Research Organizations in Austria
Contract Research Organizations in Bangladesh
Contract Research Organizations in Costa Rica
Contract Research Organizations in Cote d'Ivoire
Contract Research Organizations in Croatia
Contract Research Organizations in Israel
Contract Research Organizations in Pakistan
Contract Research Organizations in Qatar
Contract Research Organizations in Rwanda
Contract Research Organizations in Senegal
Contract Research Organizations in Singapore
Contract Research Organizations in Switzerland
Contract Research Organizations in Venezuela
CRO list by country
CROs in Djibouti
SGS
All CROs in Djibouti
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe